Why the study?
Transient abnormal myelopoiesis and myeloid-leukemia associated with Down syndrome share overlapping features but must be accurately distinguished to provide appropriate management.
Answers are grounded in this paper and cite their sources.
Highlights diagnostic features to differentiate between transient abnormal myelopoiesis and myeloid-leukemia associated with Down syndrome.
Down syndrome (DS) is defined by an extra copy of chromosome 21 and confers an increased susceptibility to hematological disorders. Transient abnormal myelopoiesis (TAM) and myeloid-leukemia associated with Down syndrome (ML-DS) are two conditions that need to be accurately diagnosed to provide appropriate management. Both TAM and ML-DS are characterized by proliferation of megakaryoblasts carrying a mutation in the GATA1 gene. Here, we report four cases with educational significance, highlighting typical diagnostic features that facilitate the differentiation between these two conditions, thereby assisting clinicians and medical laboratory professionals in effectively managing and monitoring these patients.
No takes yet. Share an insight, caveat, or question.
Boumeghar et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: